Prof. Dr. José Luis Guil-Guerrero is a member of the Food Technology Division, Agronomy Dept., University of Almería (Spain). He has a degree in both biology and pharmacy, and is PhD in Nutrition. His research is linked to the cytotoxicity of food extracts, analysis of phytochemicals, design of structured lipids, and paleodiet.
Prof. Dr. José A. M. Prates (h index of 41, Scopus) is a Full Professor (since 2010) and the Head of the Quality of Animal Products Laboratory (since 2000) at the Faculty of Veterinary Medicine of the University of Lisbon (Portugal). He holds a Bachelor’s degree in Pharmaceutical Sciences (1990), a Master’s degree in Biochemistry (1993), a Ph.D. in Animal Science and Technology (2000), and a degree in Habilitation in Animal Science and Technology (2007). He was a member of the Management Committee of COST Action FA1401 (PiGutNet) and COST Action CA15215 (IPEMA), both involving more than 20 countries each. He is a Foundation Partner (2008) and Manager of the biotechnology company NZYTech—Genes and Enzymes, Ltd. His research interests are related to the development of novel feeding strategies to improve livestock production efficiency, carcass composition, meat quality, and human health. The manipulation of fat and bioactive fatty acid deposition in livestock species is a major research topic of his. The supplementation of monogastric diets with recombinant carbohydrate-active enzymes (CAZymes) is also a major approach.
Dr. Paula Alexandra Lopes is a Researcher at the CIISA—Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, Lisboa, Portugal. She
holds a Ph.D. in Biochemistry and Physiology. She is a lipid researcher whose career aims at identifying mechanism-based molecular targets for obesity therapeutic and neurodegenerative
diseases intervention using disease models (genetic and diet-induced), genomics and DNA-based approaches for lipid metabolism regulation and inflammation. The main focus stands on cellular and molecular mechanisms that regulate adipose and neuronal cell fate, extending our mechanistic evaluation of biological systems from cellular to organism levels. The ultimate goal is to control gene
expression and signalling networks involved in cell differentiation and proliferation, based on genetic susceptibilities and cellular contexts, and to exploit novel therapeutic strategies to counteract neurological disorders (such as Alzheimer’s disease) and obesity onset. She is also interested in the
development of nutritional strategies and bioactive lipids from animal origin and oxidative stress in health and disease.
